CANADIAN NAT RES LTD MED TER holding history
As of Nov. 6, 2026 (UTC)
| March 31, 2025 | 27,266,207 | $839,799,176 | 11.04% | Withheld — Comparison unavailable: Comparable change withheld pending corporate-action review | April 30, 2025 |
| June 30, 2025 | 22,126,877 | $694,783,938 | 9.33% | Withheld — Comparison unavailable: Comparable change withheld pending corporate-action review | Aug. 6, 2025 |
| Sept. 30, 2025 | 20,908,511 | $668,236,012 | 9.21% | Withheld — Comparison unavailable: Comparable change withheld pending corporate-action review | Nov. 4, 2025 |
| Dec. 31, 2025 | 18,775,420 | $635,547,967 | 8.90% | Withheld — Comparison unavailable: Comparable change withheld pending corporate-action review | Feb. 3, 2026 |
| March 31, 2026 | 16,541,598 | $806,072,071 | 10.75% | Withheld — Comparison unavailable: Comparable change withheld pending corporate-action review | May 1, 2026 |
| June 30, 2026 | 16,462,508 | $650,269,066 | 8.04% | Withheld — Comparison unavailable: Comparable change withheld pending corporate-action review | Aug. 11, 2026 |
| Sept. 30, 2026 | 15,171,307 | $714,113,420 | 8.53% | Withheld — Comparison unavailable: Comparable change withheld pending corporate-action review | Nov. 2, 2026 |
7 rows · Sort by column; scroll horizontally for more.
No rows match these filters.
Schedule 13G disclosures
No verified related disclosures are included in this freeze.
About reported holdings
13F reports quarter-end securities, excluding cash and shorts. Position changes do not establish trades, motives or returns; portfolio weights use disclosed 13F value.